During the past decade, HOP la Colombière conducted 8 clinical trials. In the 10-year time frame, 8 clinical trials started and 1 clinical trials were completed, i.e. on average, 12.5% percent of trials that started reached the finish line to date. In the past 5 years, 5 clinical trials started and 1 clinical trials were completed. i.e. 20% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "HOP la Colombière" #1 collaborator was "H. Lundbeck A/S" with 1 trials as a collaborator. Other collaborators include -1 different institutions and companies that were collaborators in the rest 1 trials.

According to Clinical.Site data, the most researched conditions in "HOP la Colombière" are "Schizophrenia" (5 trials), "Borderline Personality Disorder" (1 trials), "Depressive Disorder, Major" (1 trials) and "Mental Disorders" (1 trials). Many other conditions were trialed in "HOP la Colombière" in a lesser frequency.

Most popular intervention types in "HOP la Colombière" are "Drug" (6 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (5 trials), "BI 1358894" (2 trials), "BI 425809" (2 trials), "BI 409306" (1 trials) and "Iclepertin" (1 trials). Other intervention names were less common.

The vast majority of trials in "HOP la Colombière" are 8 trials for "All" genders.

Currently, there are NaN active trials in "HOP la Colombière". undefined are not yet recruiting, 4 are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 2 completed trials in HOP la Colombière, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in HOP la Colombière, 0 "Phase 1" clinical trials were conducted, 4 "Phase 2" clinical trials and 2 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".